What is the current stock price of Canopus BioPharma Incorporated (CBIA)?

As of the latest market data, Canopus BioPharma Incorporated (CBIA) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does Canopus BioPharma Incorporated (CBIA) pay a dividend?

Based on current data, Canopus BioPharma Incorporated does not have a confirmed active dividend policy.

What is the market cap of Canopus BioPharma Incorporated?

The current market capitalization of Canopus BioPharma Incorporated (CBIA) is approximately unavailable.

CBIA

Canopus BioPharma Incorporated·Financial Services

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals. The company was founded in 1996 as Canopus Corporation and changed its name in 2007. Canopus BioPharma Incorporated is based in Santa Monica, California.

Sector

Financial Services

Industry

Shell Companies

IPO Date

1999-12-31

Beta

9.40

Websitewww.blueheaven.cafe↗